Suchergebnisse - "Min, Gi-June"

PubPharm (100)

81

A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation

enthalten in: International journal of hematology | 2019

von Min, G. | Park, S. | Park, S. | +11

82

A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation

enthalten in: International journal of hematology | 2019

von Min, G. | Park, S. | Park, S. | +11

83

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma

enthalten in: Annals of hematology | 2019

von Jeon, Y. | Yoon, S. | Min, G. | +12

84

Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

enthalten in: Clinical lymphoma, myeloma & leukemia | 2019

von Jeon, Y. | Yoon, S. | Min, G. | +12

85

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma

enthalten in: Annals of hematology | 2019

von Jeon, Y. | Yoon, S. | Min, G. | +12

86

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma

enthalten in: Annals of hematology | 2019

von Jeon, Y. | Yoon, S. | Min, G. | +12

87

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma

enthalten in: Annals of hematology | 2019

von Jeon, Y. | Yoon, S. | Min, G. | +12

88

Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia

enthalten in: Cancer | 2019

von Yoon, J. | Min, G. | Park, S. | +11

89

Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas

enthalten in: Bone marrow transplantation | 2019

von Yoon, J. | Min, G. | Park, S. | +10

90

Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019

von Park, S. | Jeon, Y. | Min, G. | +13